Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ioannidis, J. P. A.
Right arrow Articles by O’Brien, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ioannidis, J. P. A.
Right arrow Articles by O’Brien, T. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2002; 156:204-210.
Copyright © 2002 by the Johns Hopkins Bloomberg School of Public Health


SPECIAL ARTICLE

Commentary: Meta-analysis of Individual Participants’ Data in Genetic Epidemiology

John P. A. Ioannidis1,2, Philip S. Rosenberg3, James J. Goedert4 and Thomas R. O’Brien4

1 Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, and Ioannina Biomedical Research Institute, Foundation for Research and Technology–Hellas, Ioannina, Greece.
2 Department of Medicine, Tufts University School of Medicine, Boston, MA.
3 Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
4 Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.

Received for publication October 9, 2001; accepted for publication March 14, 2002.

bias, epidemiology; genetics; meta-analysis

Abbreviations: Abbreviations: AIDS, acquired immunodeficiency syndrome; CCR2, C-C chemokine receptor 2; CCR5, C-C chemokine receptor 5; CDC, Centers for Disease Control and Prevention; D32, 32-base pair deletion; HIV-1, human immunodeficiency virus type 1; MIPD, meta-analysis of individual participants’ data; MPL, meta-analysis of the published literature; SDF-1, stromal cell-derived factor 1.

The first 150 words of the full text of this article appear below.


    INTRODUCTION
 
With more than 30,000 human genes and several genetic markers per gene, the potential for identifying genetic associations for various diseases is enormous (1–5). Genetic effects are often modest: Many subjects must be studied, and single epidemiologic studies are unlikely to be definitive. Meta-analysis may help meet the challenge of synthesizing data from studies of genetic epidemiology (6). Several meta-analyses of published literature (MPL) have already appeared in the field (7). Meta-analysis of epidemiologic studies (8) is controversial. Critics have focused on variability in study designs, poor data quality, insufficient confounder adjustment, publication bias, and spuriously narrow confidence intervals (9–12). Use of the raw information from individual subjects instead of published data avoids some of these problems. Meta-analysis of individual patient data has been applied successfully in randomized trials (13, 14). The equivalent . . . [Full Text of this Article]


    CONDUCT OF THE MPL
 

    CONDUCT OF THE MIPD
 

    ADVANTAGES OF MIPD (table 1)
 
Data
Completeness of information
Standardization of information
Analysis
Time-to-event analyses
Adjusted/multivariate analyses
Linkage disequilibrium
Alternative genetic models and effects of multiple genes
Population subgroups
Interpretation
Heterogeneity
Assessing sampling bias
Other
Establishing collaborations

    DISADVANTAGES OF MIPD (table 1)
 
Data
Interpretation
Resources

    FINAL COMMENT
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin TrialsHome page
J. P. Ioannidis and T. A Trikalinos
An exploratory test for an excess of significant findings
Clinical Trials, June 1, 2007; 4(3): 245 - 253.
[Abstract] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. P. A. Ioannidis
Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.
J Natl Cancer Inst, October 4, 2006; 98(19): 1350 - 1353.
[Full Text] [PDF]


Home page
DiabetesHome page
C. Huth, I. M. Heid, C. Vollmert, C. Gieger, H. Grallert, J. K. Wolford, B. Langer, B. Thorand, N. Klopp, Y. H. Hamid, et al.
IL6 Gene Promoter Polymorphisms and Type 2 Diabetes: Joint Analysis of Individual Participants' Data From 21 Studies.
Diabetes, October 1, 2006; 55(10): 2915 - 2921.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. M. Maraganore, M. de Andrade, A. Elbaz, M. J. Farrer, J. P. Ioannidis, R. Kruger, W. A. Rocca, N. K. Schneider, T. G. Lesnick, S. J. Lincoln, et al.
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
JAMA, August 9, 2006; 296(6): 661 - 670.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
J. P A Ioannidis
Commentary: Grading the credibility of molecular evidence for complex diseases
Int. J. Epidemiol., June 1, 2006; 35(3): 572 - 578.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. A. Smith-Warner, D. Spiegelman, J. Ritz, D. Albanes, W. L. Beeson, L. Bernstein, F. Berrino, P. A. van den Brandt, J. E. Buring, E. Cho, et al.
Methods for Pooling Results of Epidemiologic Studies: The Pooling Project of Prospective Studies of Diet and Cancer
Am. J. Epidemiol., June 1, 2006; 163(11): 1053 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. P. A. Ioannidis, J. Bernstein, P. Boffetta, J. Danesh, S. Dolan, P. Hartge, D. Hunter, P. Inskip, M.-R. Jarvelin, J. Little, et al.
A Network of Investigator Networks in Human Genome Epidemiology
Am. J. Epidemiol., August 15, 2005; 162(4): 302 - 304.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. A. Kyzas, K. T. Loizou, and J. P. A. Ioannidis
Selective Reporting Biases in Cancer Prognostic Factor Studies
J Natl Cancer Inst, July 20, 2005; 97(14): 1043 - 1055.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
M M Rovers, N Black, G G Browning, R Maw, G A Zielhuis, and M P Haggard
Grommets in otitis media with effusion: an individual patient data meta-analysis
Arch. Dis. Child., May 1, 2005; 90(5): 480 - 485.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Ntais, A. Polycarpou, and J. P.A. Ioannidis
Association of GSTM1, GSTT1, and GSTP1 Gene Polymorphisms with the Risk of Prostate Cancer: A Meta-analysis
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 176 - 181.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. P. A. Ioannidis, S. H. Ralston, S. T. Bennett, M. L. Brandi, D. Grinberg, F. B. Karassa, B. Langdahl, J. B. J. van Meurs, L. Mosekilde, S. Scollen, et al.
Differential Genetic Effects of ESR1 Gene Polymorphisms on Osteoporosis Outcomes
JAMA, November 3, 2004; 292(17): 2105 - 2114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis
Vitamin D Receptor Gene Polymorphisms and Risk of Prostate Cancer: A Meta-analysis
Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1395 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. E. Heffner, K. Highland, and L. K. Brown
A Meta-analysis Derivation of Continuous Likelihood Ratios for Diagnosing Pleural Fluid Exudates
Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1591 - 1599.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Little, M. J. Khoury, L. Bradley, M. Clyne, M. Gwinn, B. Lin, M.-L. Lindegren, and P. Yoon
The Human Genome Project Is Complete. How Do We Develop a Handle for the Pump?
Am. J. Epidemiol., April 15, 2003; 157(8): 667 - 673.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. E. Caporaso
Why Have We Failed to Find the Low Penetrance Genetic Constituents of Common Cancers?
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1544 - 1549.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Little, L. Bradley, M. S. Bray, M. Clyne, J. Dorman, D. L. Ellsworth, J. Hanson, M. Khoury, J. Lau, T. R. O'Brien, et al.
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease Associations
Am. J. Epidemiol., August 15, 2002; 156(4): 300 - 310.
[Abstract] [Full Text] [PDF]